# NCT01850524 (NCT01850524)

> IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01850524
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Millennium Pharmaceuticals, Inc.
- Conditions: Multiple Myeloma
- Interventions: Ixazomib; Placebo; Dexamethasone; Lenalidomide
- Enrollment: 705
- Primary outcome: Progression Free Survival (PFS)

## Indexed commentary on NCT01850524 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=nct01850524